Tobin Schilke Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity

CRNX Quotes by TradingView

Tobin Schilke is Chief Financial Officer of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 52,000 shares of CRNX, which is worth approximately $1.84 Million. The most recent transaction as insider was on Mar 10, 2025, when has been sold 52,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52K
n/a 3M change
n/a 12M change
Total Value Held $1.84 Million

Tobin Schilke Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2025
BUY
Grant, award, or other acquisition
-
52,000 Added 50.0%
52,000 Common Stock

Also insider at

RVNC
Revance Therapeutics, Inc. Healthcare
CFO
TS

Tobin Schilke

Chief Financial Officer
Nashville, TN

Track Institutional and Insider Activities on CRNX

Follow Crinetics Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRNX shares.

Notify only if

Insider Trading

Get notified when an Crinetics Pharmaceuticals, Inc. insider buys or sells CRNX shares.

Notify only if

News

Receive news related to Crinetics Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRNX